Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood leptin amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000780,serum leptin level,,,,1.67,ng/ml,0.37,0.9063,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101911,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood leptin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000780,serum leptin level,,,,53.97,ng/ml,2.34,6.1911,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101912,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood glucose amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000543,serum glucose level,,,,124.5,mg/dl,6.4,15.6767,MMO:0000316,serum glucose analysis,,0.0,,,,,fasting (for 16 hours),101913,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood glucose amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000543,serum glucose level,,,,136.33,mg/dl,5.27,13.9431,MMO:0000316,serum glucose analysis,,0.0,,,,,fasting (for 16 hours),101914,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood insulin amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000358,serum insulin level,,,,0.000055,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101915,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood insulin amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000358,serum insulin level,,,,0.000318,mg/dl,1.0E-4,4.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),101916,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood triglyceride amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000360,serum triglyceride level,,,,102.25,mg/dl,25.98,63.6377,MMO:0000136,serum triglyceride analysis,,0.0,,,,,fasting (for 16 hours),101917,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000360,serum triglyceride level,,,,1559.93,mg/dl,353.89,936.3049,MMO:0000136,serum triglyceride analysis,,0.0,,,,,fasting (for 16 hours),101918,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood cholesterol amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000363,serum total cholesterol level,,,,116.25,mg/dl,11.59,28.3896,MMO:0000132,serum total cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101919,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood cholesterol amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000363,serum total cholesterol level,,,,371.14,mg/dl,39.21,103.7399,MMO:0000132,serum total cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101920,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood LDL cholesterol amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000362,serum low density lipoprotein cholesterol level,,,,24,mg/dl,2.94,7.2015,MMO:0000134,serum low-density lipoprotein-cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101921,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood LDL cholesterol amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000362,serum low density lipoprotein cholesterol level,,,,73.85,mg/dl,7.15,18.9171,MMO:0000134,serum low-density lipoprotein-cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101922,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood HDL cholesterol amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000361,serum high density lipoprotein cholesterol level,,,,26.75,mg/dl,1.11,2.7189,MMO:0000133,serum high-density lipoprotein-cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101923,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood HDL cholesterol amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000361,serum high density lipoprotein cholesterol level,,,,50.14,mg/dl,2.3,6.0852,MMO:0000133,serum high-density lipoprotein-cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101924,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood cholesterol amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0003215,serum low density lipoprotein cholesterol to high density lipoprotein cholesterol ratio,,ldl/hdl,,0.89,,0.09,0.2205,MMO:0000133,serum high-density lipoprotein-cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101925,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood cholesterol amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,6,,CMO:0003215,serum low density lipoprotein cholesterol to high density lipoprotein cholesterol ratio,,ldl/hdl,,1.59,,0.15,0.3674,MMO:0000133,serum high-density lipoprotein-cholesterol measurement test,,0.0,,,,,fasting (for 16 hours),101926,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood aspartate transaminase amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000581,serum aspartate aminotransferase activity level,,,,57,U/l,1.52,3.7232,MMO:0000179,automated blood analysis,,0.0,,,,,fasting (for 16 hours),101927,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood aspartate transaminase amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000581,serum aspartate aminotransferase activity level,,,,67.33,U/l,4.67,12.3557,MMO:0000179,automated blood analysis,,0.0,,,,,fasting (for 16 hours),101928,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood alanine transaminase amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000575,serum alanine aminotransferase activity level,,,,24.67,U/l,0.88,2.1556,MMO:0000179,automated blood analysis,,0.0,,,,,fasting (for 16 hours),101929,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood alanine transaminase amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000575,serum alanine aminotransferase activity level,,,,39.25,U/l,2.63,6.9583,MMO:0000179,automated blood analysis,,0.0,,,,,fasting (for 16 hours),101930,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood urea nitrogen amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000587,serum urea nitrogen level,,,,19.98,mg/dl,1.86,4.5561,MMO:0000274,serum urea nitrogen analysis,,0.0,,,,,fasting (for 16 hours),101931,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood urea nitrogen amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000587,serum urea nitrogen level,,,,76.21,mg/dl,13.56,35.8764,MMO:0000274,serum urea nitrogen analysis,,0.0,,,,,fasting (for 16 hours),101932,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood creatinine amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000057,serum creatinine level,,,,0.32,mg/dl,0.03,0.0735,MMO:0000271,serum creatinine analysis,,0.0,,,,,fasting (for 16 hours),101933,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood creatinine amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000057,serum creatinine level,,,,1.09,mg/dl,0.19,0.5027,MMO:0000271,serum creatinine analysis,,0.0,,,,,fasting (for 16 hours),101934,fasting (for 16 hours) 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",total urine protein amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000591,urine protein level,,,,336.29,mg/d,19.58,47.961,MMO:0000334,urine protein analysis,,0.0,,,,,control condition,101935,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",total urine protein amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000591,urine protein level,,,,735.52,mg/d,93.97,248.6213,MMO:0000334,urine protein analysis,,0.0,,,,,control condition,101936,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",glomerular filtration trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0002070,creatinine clearance to total kidney weight ratio,,,,1.25,ml/min/g,0.12,0.2939,MMO:0000275,urine creatinine analysis,,0.0,,,,,control condition,101937,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",glomerular filtration trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0002070,creatinine clearance to total kidney weight ratio,,,,0.2,ml/min/g,0.03,0.0794,MMO:0000275,urine creatinine analysis,,0.0,,,,,control condition,101938,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",glomerular filtration trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0001211,creatinine clearance to body weight ratio,,,,0.91,ml/min/100g,0.06,0.147,MMO:0000275,urine creatinine analysis,,0.0,,,,,control condition,101939,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",glomerular filtration trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0001211,creatinine clearance to body weight ratio,,,,0.18,ml/min/100g,0.02,0.0529,MMO:0000275,urine creatinine analysis,,0.0,,,,,control condition,101940,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",body mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000012,body weight,,,,443.75,g,21.62,52.958,MMO:0000016,body weighing method,,0.0,,,,,control condition,101885,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",body mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000012,body weight,,,,536.92,g,6.98,18.4673,MMO:0000016,body weighing method,,0.0,,,,,control condition,101886,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",tibia length,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0001731,tibia straight segment length,,,,40.27,mm,0.24,0.5879,MMO:0000119,body measuring method,,0.0,,,,,control condition,101887,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",tibia length,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0001731,tibia straight segment length,,,,36.47,mm,0.12,0.3175,MMO:0000119,body measuring method,,0.0,,,,,control condition,101888,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",arterial blood pressure trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000004,systolic blood pressure,,,,137.7,mmHg,3.04,7.4464,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,101889,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",arterial blood pressure trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000004,systolic blood pressure,,,,210.62,mmHg,2.54,6.7202,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,101890,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart pumping trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000002,heart rate,,,,417.32,beats/min,13.71,33.5825,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,101891,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart pumping trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000002,heart rate,,,,400.73,beats/min,15.4,40.7446,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,101892,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0001198,heart weight to tibia length ratio,,,,0.3271,g/cm,0.0143,0.035,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101893,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0001198,heart weight to tibia length ratio,,,,0.4222,g/cm,0.0029,0.0077,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101894,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart left ventricle mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0002787,heart left ventricle weight to tibia length ratio,,lv/tl,,0.2422,g/cm,0.0102,0.025,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101895,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart left ventricle mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0002787,heart left ventricle weight to tibia length ratio,,lv/tl,,0.3269,g/cm,0.0037,0.0098,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101896,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart left ventricle mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0003210,heart left ventricle weight to right ventricle weight ratio,,lv/rv,,4.21,,0.05,0.1225,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101897,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart left ventricle mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0003210,heart left ventricle weight to right ventricle weight ratio,,lv/rv,,4.74,,0.12,0.3175,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101898,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart left atrium mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0003193,heart left atrium weight to tibia length ratio,,a/tl,,2.06,mg/mm,0.23,0.5634,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101899,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",heart left atrium mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0003193,heart left atrium weight to tibia length ratio,,a/tl,,2.55,mg/mm,0.14,0.3704,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101900,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",kidney mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0001199,both kidneys wet weight to tibia length ratio,,,,0.7841,g/cm,0.0636,0.1558,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101901,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",kidney mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0001199,both kidneys wet weight to tibia length ratio,,,,1.2889,g/cm,0.0379,0.1003,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101902,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",liver mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0002995,liver weight to tibia length ratio,,liv/tl,,312.19,mg/mm,25.29,61.9476,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101903,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",liver mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0002995,liver weight to tibia length ratio,,liv/tl,,600.11,mg/mm,42.14,111.492,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101904,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",retroperitoneal fat pad mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0002990,retroperitoneal fat pad weight to tibia length ratio,,rf/tl,,178.02,mg/mm,31.55,77.2814,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101905,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",retroperitoneal fat pad mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0002990,retroperitoneal fat pad weight to tibia length ratio,,rf/tl,,839.28,mg/mm,33.0,87.3098,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101906,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",inguinal fat pad mass,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0002991,inguinal fat pad weight to tibia length ratio,,if/tl,,158.77,mg/mm,27.34,66.969,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101907,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",inguinal fat pad mass,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0002991,inguinal fat pad weight to tibia length ratio,,if/tl,,795.02,mg/mm,41.33,109.3489,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,101908,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",total life span,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0003803,ratio of survivors of metabolic syndrome to total study population during a period of time,,ratio of survivors of metabolic syndrome to total study population during a period of time (CMO:0003803),,100,%,,,MMO:0000344,necropsy,,0.0,,,,,control condition,101909,control condition 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",total life span,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,20,,CMO:0003803,ratio of survivors of metabolic syndrome to total study population during a period of time,,ratio of survivors of metabolic syndrome to total study population during a period of time (CMO:0003803),,35,%,,,MMO:0000344,necropsy,,0.0,,,,,control condition,101910,control condition